Science & Enterprise subscription

Follow us on Twitter

  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 17 hours ago
  • New post on Science and Enterprise: BARDA to Buy $2B in Covid-19 Vaccines, Therapies https://t.co/LFM1IUr1rN #Science #Business
    about 17 hours ago
  • A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
    about 24 hours ago
  • New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
    about 24 hours ago
  • If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
    about 2 days ago

Please share Science & Enterprise

University, Company to Collaborate on Cancer Imaging

Hugh Cormican (QUBIS Ltd.)

Hugh Cormican (QUBIS Ltd.)

Queen’s University in Belfast, Northern Ireland, U.K., is partnering with start-up company Cirdan Imaging Ltd., also in Northern Ireleand, to develop new imaging tools for the detection and treatment of cancer. As part of the deal, QUBIS Ltd., the university’s technology transfer subsidiary, will take an equity stake in Cirdan Imaging.

The agreement involves research to develop imaging equipment using X-rays and near-infrared fluorescence to help in the detection, diagnosis, and treatment of cancer. The new devices will be used to better discriminate between healthy and malignant tissue in diagnostic procedures and cancer surgery.

Cirdan is developing its first new device, an imaging tool to help radiologists to take a biopsy from a suspect lesion to help diagnose breast cancer.  The company says it expects to launch the product in the next 12 months.

“We know that speed of detection and treatment of cancer is critical to patient outcomes,” says Hugh Cormican, CEO of Cirdan Imaging, “and we hope that through this new faster, more efficient technology, patient outcomes and survival will be improved.” Cormican (pictured at top), a former physics student at Queens, previously worked with QUBIS to start up Andor Technology, a scientific and industrial imaging company in Belfast.

Financial aspects of the agreement were not disclosed. QUBIS says this is the university’s first equity deal of this kind.

Read more:

*     *     *

Please share Science & Enterprise ...

2 comments to University, Company to Collaborate on Cancer Imaging